Jeng-Wei Lu1, Shu-Hui Lin2,3, Chung-Min Yeh2,4, Kun-Tu Yeh2,5, Lan-Ru Huang3, Chia-Yu Chen2, Yueh-Min Lin6,5. 1. Department of Biological Sciences, National University of Singapore, Singapore, Singapore. 2. Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan, R.O.C. 3. Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan, R.O.C. 4. Department of Medical Technology, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli, Taiwan, R.O.C. 5. School of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C. 6. Department of Surgical Pathology, Changhua Christian Hospital, Changhua, Taiwan, R.O.C. 93668@cch.org.tw.
Abstract
BACKGROUND/AIM: Casein kinase 1 epsilon (CK1ε) is a member of the casein kinase 1 family, which includes highly conserved and ubiquitous serine/threonine protein kinases. Recent research has revealed that CK1ε plays an important role in a variety of human cancer types; however, its role in human melanoma remains unclear. The aim of this study was to elucidate the clinical role of CK1ε in patients with melanoma. PATIENTS AND METHODS: Samples from 34 patients with melanoma were analyzed by immunohistochemical staining. Formalin-fixed paraffin-embedded tissue microarrays were also examined by two histopathologists to assess CK1ε protein expression in humans. RESULTS: Cytoplasmic CK1ε protein expression was significantly lower in tumor tissue than in normal tissue. Lack of cytoplasmic CK1ε protein was significantly correlated with distant metastasis (p=0.022) and poorer survival (p=0.030). However, Kaplan-Meier survival analysis revealed that elevated expression of cytoplasmic CK1ε protein was not significantly associated with the overall survival of patients with melanoma. Univariate and multivariate analyses demonstrated that lack of cytoplasmic CK1ε protein expression was related to distant metastasis (p<0.001 and p=0.004), showing that CK1ε was a prognostic factor. CONCLUSION: CK1ε protein expression might serve as a prognostic indicator in the treatment of patients with melanoma. Copyright
BACKGROUND/AIM: Casein kinase 1 epsilon (CK1ε) is a member of the casein kinase 1 family, which includes highly conserved and ubiquitous serine/threonine protein kinases. Recent research has revealed that CK1ε plays an important role in a variety of human cancer types; however, its role in human melanoma remains unclear. The aim of this study was to elucidate the clinical role of CK1ε in patients with melanoma. PATIENTS AND METHODS: Samples from 34 patients with melanoma were analyzed by immunohistochemical staining. Formalin-fixed paraffin-embedded tissue microarrays were also examined by two histopathologists to assess CK1ε protein expression in humans. RESULTS: Cytoplasmic CK1ε protein expression was significantly lower in tumor tissue than in normal tissue. Lack of cytoplasmic CK1ε protein was significantly correlated with distant metastasis (p=0.022) and poorer survival (p=0.030). However, Kaplan-Meier survival analysis revealed that elevated expression of cytoplasmic CK1ε protein was not significantly associated with the overall survival of patients with melanoma. Univariate and multivariate analyses demonstrated that lack of cytoplasmic CK1ε protein expression was related to distant metastasis (p<0.001 and p=0.004), showing that CK1ε was a prognostic factor. CONCLUSION: CK1ε protein expression might serve as a prognostic indicator in the treatment of patients with melanoma. Copyright
Authors: Ahmedin Jemal; Mona Saraiya; Pragna Patel; Sai S Cherala; Jill Barnholtz-Sloan; Julian Kim; Charles L Wiggins; Phyllis A Wingo Journal: J Am Acad Dermatol Date: 2011-11 Impact factor: 11.527
Authors: Dirk Schadendorf; Alexander C J van Akkooi; Carola Berking; Klaus G Griewank; Ralf Gutzmer; Axel Hauschild; Andreas Stang; Alexander Roesch; Selma Ugurel Journal: Lancet Date: 2018-09-15 Impact factor: 79.321
Authors: M Arnold; C Holterhues; L M Hollestein; J W W Coebergh; T Nijsten; E Pukkala; B Holleczek; L Tryggvadóttir; H Comber; M J Bento; Ch S Diba; R Micallef; M Primic-Žakelj; M I Izarzugaza; J Perucha; R Marcos-Gragera; J Galceran; E Ardanaz; R Schaffar; A Pring; E de Vries Journal: J Eur Acad Dermatol Venereol Date: 2013-08-21 Impact factor: 6.166
Authors: Marc Flajolet; Gen He; Myriam Heiman; Angie Lin; Angus C Nairn; Paul Greengard Journal: Proc Natl Acad Sci U S A Date: 2007-02-27 Impact factor: 11.205